GGT1 antibody
GTX101198
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetGGT1
Overview
- SupplierGeneTex
- Product NameGGT1 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.71 mg/ml
- ConjugateUnconjugated
- Gene ID2678
- Target nameGGT1
- Target descriptiongamma-glutamyltransferase 1
- Target synonymsCD224, D22S672, D22S732, GGT, GGT 1, GGTD, GTG, glutathione hydrolase 1 proenzyme, gamma-glutamyltranspeptidase 1, leukotriene-C4 hydrolase, testicular tissue protein Li 73
- HostRabbit
- IsotypeIgG
- Protein IDP19440
- Protein NameGlutathione hydrolase 1 proenzyme
- Scientific DescriptionThe enzyme encoded by this gene catalyzes the transfer of the glutamyl moiety of glutathione to a variety of amino acids and dipeptide acceptors. The enzyme is composed of a heavy chain and a light chain, which are derived from a single precursor protein, and is present in tissues involved in absorption and secretion. This enzyme is a member of the gamma-glutamyltransferase protein family, of which many members have not yet been fully characterized and some of which may represent pseudogenes. This gene is classified as type I gamma-glutamyltransferase. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Iyama T, Takata T, Yamada K, et al. A novel method for assessing the renal biopsy specimens using an activatable fluorescent probe. Sci Rep. 2020,10(1):12094. doi: 10.1038/s41598-020-69077-wRead this paper
- Tiu AC, Yang J, Asico LD, et al. Lipid rafts are required for effective renal D(1) dopamine receptor function. FASEB J. 2020,34(5):6999-7017. doi: 10.1096/fj.201902710RRRead this paper
- Zhou Q, Shao S, Wang J, et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat Nanotechnol. 2019,14(8):799-809. doi: 10.1038/s41565-019-0485-zRead this paper
- Maclean KN, Jiang H, Aivazidis S, et al. Taurine treatment prevents derangement of the hepatic γ-glutamyl cycle and methylglyoxal metabolism in a mouse model of classical homocystinuria: regulatory crosstalk between thiol and sulfinic acid metabolism. FASEB J. 2018,32(3):1265-1280. doi: 10.1096/fj.201700586RRead this paper
- Tobe R, Carlson BA, Tsuji PA, et al. Differences in Redox Regulatory Systems in Human Lung and Liver Tumors Suggest Different Avenues for Therapy. Cancers (Basel). 2015,7(4):2262-76. doi: 10.3390/cancers7040889Read this paper







